Impact of Stent Length on Short Term Outcomes in Patients With Stable Coronary Disease Undergoing PCI

April 9, 2019 updated by: Mohamed Abd elbaset Hassan, Assiut University

Impact of Stent Length on Short Term Outcomes in Patients With Stable Coronary Artery Disease Undergoing PCI

Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI

Study Overview

Detailed Description

Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI. The investigators will follow up patient clinically and use lab investigation.

Study Type

Observational

Enrollment (Anticipated)

1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients with stable coronary artery disease undergoing PCI

Description

Inclusion Criteria:

  • patient was CAD referred for elective PC as single vessel

Exclusion Criteria:

  • patients admitted ACS patients with primary PCI PTCA without stenting No complete revascularization PCI-related coronary complication (diessaction,no really)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
patients with coronary artery diseas undergoing PCI
Effect of stent length on patients with coronary artery undergoing PCI
stent length in patients undergoing PCI (Drug Eluting Stent)
stent length in patients undergoing PCI (Drug Eluting Stent)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI
Time Frame: 3 months
to study effect of stent length in patients undergoing PCI
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

July 1, 2019

Primary Completion (ANTICIPATED)

June 30, 2020

Study Completion (ANTICIPATED)

September 30, 2020

Study Registration Dates

First Submitted

March 26, 2019

First Submitted That Met QC Criteria

April 9, 2019

First Posted (ACTUAL)

April 11, 2019

Study Record Updates

Last Update Posted (ACTUAL)

April 11, 2019

Last Update Submitted That Met QC Criteria

April 9, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stable Chronic Angina

3
Subscribe